Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Medical ImagingCT MRI Xray

PUBLISHER: TechSci Research | PRODUCT CODE: 1881485

Cover Image

PUBLISHER: TechSci Research | PRODUCT CODE: 1881485

Fiducial Markers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Modality, By Cancer Type, By End User, By Region and Competition, 2020-2030F

PUBLISHED:
PAGES: 187 Pages
DELIVERY TIME: 2-3 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4500
PDF and Excel (Multi-User License)
USD 5500
PDF and Excel (Custom Research License)
USD 8000

Add to Cart

We offer 8 hour analyst time for an additional research. Please contact us for the details.

Description

Table of Contents

The Global Fiducial Markers Market, valued at USD 97.38 Million in 2024, is projected to experience a CAGR of 5.3% to reach USD 132.75 Million by 2030. Fiducial markers are small, implantable objects utilized in medical imaging to establish precise reference points for guiding radiation therapy and surgical procedures, thereby enabling accurate tumor localization and minimizing collateral damage to healthy tissue. The global market for these markers is primarily propelled by the increasing worldwide incidence of cancer, the expanding adoption of advanced imaging modalities like MRI and CBCT, and continuous technological advancements in precision radiotherapy techniques.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 97.38 Million
Market Size 2030USD 132.75 Million
CAGR 2025-20305.3%
Fastest Growing SegmentMetal Based Markers
Largest MarketNorth America

Key Market Drivers

The rising global incidence of cancer significantly propels demand for fiducial markers by expanding the patient population requiring precise radiation therapy. Growing cancer prevalence necessitates accurate tumor localization, particularly in sensitive anatomical regions. Fiducial markers are essential for precision in modern oncology, enhancing therapeutic efficacy and minimizing collateral damage. According to the American Cancer Society, in April 2024, lung cancer was the most frequently diagnosed cancer in 2022, with approximately 2.5 million new cases globally, highlighting a substantial disease burden often necessitating targeted radiation treatment. This prevalence drives continuous demand for accurate therapeutic guidance.

Key Market Challenges

The significant cost associated with fiducial marker implantation procedures presents a considerable impediment to the growth of the Global Fiducial Markers Market. These expenses, encompassing the markers, surgical expertise, specialized equipment, and necessary follow-up imaging for precise placement, restrict widespread adoption. This high expenditure is particularly challenging within healthcare systems facing budget constraints or limited reimbursement policies, directly impacting market penetration and resulting in lower utilization rates despite the acknowledged benefits of improved treatment accuracy and reduced collateral damage.

Key Market Trends

Biodegradable marker development addresses patient comfort and reduces the need for secondary removal procedures, thereby enhancing patient outcomes and potentially reducing healthcare costs. This innovation aligns with the broader medical shift toward sustainable and patient-friendly solutions. The American Medical Association, at its 2023 Interim Meeting, referred Resolution 2-I-23 concerning single-use/disposable medical devices, acknowledging the need to address adverse environmental consequences and balance fiscal expense with patient safety concerns, which reflects the growing recognition of biodegradable material benefits.

Key Market Players

  • CIVCO Radiotherapy
  • IZI Medical Products
  • Boston Scientific Corporation
  • Naslund Medical AB
  • Best Medical International, Inc.
  • Nanovi A/S
  • Carbon Medical Technologies Inc.
  • Eckert & Ziegler
  • Innovative Oncology Solutions
  • Medtronic plc

Report Scope:

In this report, the Global Fiducial Markers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fiducial Markers Market, By Product:

  • Metal-based Markers
  • Polymer-based Markers
  • Other Fiducial Markers

Fiducial Markers Market, By Modality:

  • CT/CBCT
  • MRI
  • Ultrasound
  • Radiotherapy

Fiducial Markers Market, By Cancer Type:

  • Prostate Cancer
  • Lung Cancer
  • Breast Cancer
  • Gastric Cancer
  • Other Cancers

Fiducial Markers Market, By End user:

  • Hospitals & Clinics
  • Independent Radiotherapy Centers
  • Cancer Research Centers

Fiducial Markers Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Fiducial Markers Market.

Available Customizations:

Global Fiducial Markers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Show more
Product Code: 21004

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Fiducial Markers Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Metal-based Markers, Polymer-based Markers, Other Fiducial Markers)
    • 5.2.2. By Modality (CT/CBCT, MRI, Ultrasound, Radiotherapy)
    • 5.2.3. By Cancer Type (Prostate Cancer, Lung Cancer, Breast Cancer, Gastric Cancer, Other Cancers)
    • 5.2.4. By End user (Hospitals & Clinics, Independent Radiotherapy Centers, Cancer Research Centers)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Fiducial Markers Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Modality
    • 6.2.3. By Cancer Type
    • 6.2.4. By End user
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Fiducial Markers Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Modality
        • 6.3.1.2.3. By Cancer Type
        • 6.3.1.2.4. By End user
    • 6.3.2. Canada Fiducial Markers Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Modality
        • 6.3.2.2.3. By Cancer Type
        • 6.3.2.2.4. By End user
    • 6.3.3. Mexico Fiducial Markers Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Modality
        • 6.3.3.2.3. By Cancer Type
        • 6.3.3.2.4. By End user

7. Europe Fiducial Markers Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Modality
    • 7.2.3. By Cancer Type
    • 7.2.4. By End user
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Fiducial Markers Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Modality
        • 7.3.1.2.3. By Cancer Type
        • 7.3.1.2.4. By End user
    • 7.3.2. France Fiducial Markers Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Modality
        • 7.3.2.2.3. By Cancer Type
        • 7.3.2.2.4. By End user
    • 7.3.3. United Kingdom Fiducial Markers Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Modality
        • 7.3.3.2.3. By Cancer Type
        • 7.3.3.2.4. By End user
    • 7.3.4. Italy Fiducial Markers Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Modality
        • 7.3.4.2.3. By Cancer Type
        • 7.3.4.2.4. By End user
    • 7.3.5. Spain Fiducial Markers Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Modality
        • 7.3.5.2.3. By Cancer Type
        • 7.3.5.2.4. By End user

8. Asia Pacific Fiducial Markers Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Modality
    • 8.2.3. By Cancer Type
    • 8.2.4. By End user
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Fiducial Markers Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Modality
        • 8.3.1.2.3. By Cancer Type
        • 8.3.1.2.4. By End user
    • 8.3.2. India Fiducial Markers Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Modality
        • 8.3.2.2.3. By Cancer Type
        • 8.3.2.2.4. By End user
    • 8.3.3. Japan Fiducial Markers Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Modality
        • 8.3.3.2.3. By Cancer Type
        • 8.3.3.2.4. By End user
    • 8.3.4. South Korea Fiducial Markers Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Modality
        • 8.3.4.2.3. By Cancer Type
        • 8.3.4.2.4. By End user
    • 8.3.5. Australia Fiducial Markers Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Modality
        • 8.3.5.2.3. By Cancer Type
        • 8.3.5.2.4. By End user

9. Middle East & Africa Fiducial Markers Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Modality
    • 9.2.3. By Cancer Type
    • 9.2.4. By End user
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Fiducial Markers Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Modality
        • 9.3.1.2.3. By Cancer Type
        • 9.3.1.2.4. By End user
    • 9.3.2. UAE Fiducial Markers Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Modality
        • 9.3.2.2.3. By Cancer Type
        • 9.3.2.2.4. By End user
    • 9.3.3. South Africa Fiducial Markers Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Modality
        • 9.3.3.2.3. By Cancer Type
        • 9.3.3.2.4. By End user

10. South America Fiducial Markers Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Modality
    • 10.2.3. By Cancer Type
    • 10.2.4. By End user
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Fiducial Markers Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Modality
        • 10.3.1.2.3. By Cancer Type
        • 10.3.1.2.4. By End user
    • 10.3.2. Colombia Fiducial Markers Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Modality
        • 10.3.2.2.3. By Cancer Type
        • 10.3.2.2.4. By End user
    • 10.3.3. Argentina Fiducial Markers Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Modality
        • 10.3.3.2.3. By Cancer Type
        • 10.3.3.2.4. By End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Fiducial Markers Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. CIVCO Radiotherapy
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. IZI Medical Products
  • 15.3. Boston Scientific Corporation
  • 15.4. Naslund Medical AB
  • 15.5. Best Medical International, Inc.
  • 15.6. Nanovi A/S
  • 15.7. Carbon Medical Technologies Inc.
  • 15.8. Eckert & Ziegler
  • 15.9. Innovative Oncology Solutions
  • 15.10. Medtronic plc

16. Strategic Recommendations

17. About Us & Disclaimer

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!